Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.30p
   
  • Change Today:
    -0.20p
  • 52 Week High: 12.60
  • 52 Week Low: 3.18
  • Currency: UK Pounds
  • Shares Issued: 623.91m
  • Volume: 2,991,040
  • Market Cap: £20.59m
  • RiskGrade: 328
  • Beta: 0.01

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £49,119
Lisa Baderoon 583,963 £19,271
Tim Franklin 525,000 £17,325

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 91,523,156 £3,020,264
Invesco Ltd 17,872,341 £589,787
Aviva Investors Global 11,285,180 £372,411
Alora Pharmaceuticals LLC 10,909,091 £360,000
M&G Investments 7,600,000 £250,800
Prudential plc 7,600,000 £250,800
Capital Income Builder 4,870,367 £160,722
Dr R Zimmer 4,551,553 £150,201
Odey Asset Management 3,433,319 £113,300
Rhone Trustees (Switzerland) SA 3,386,000 £111,738
Pictet Overseas Trust Corporation Limited 3,287,500 £108,488

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 3.30p
Change Today -0.20p
% Change -5.58 %
52 Week High 12.60
52 Week Low 3.18
Volume 2,991,040
Shares Issued 623.91m
Market Cap £20.59m
Beta 0.01
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.93% below the market average65.93% below the market average65.93% below the market average65.93% below the market average65.93% below the market average
2.44% below the sector average2.44% below the sector average2.44% below the sector average2.44% below the sector average2.44% below the sector average
Price Trend
97.10% above the market average97.10% above the market average97.10% above the market average97.10% above the market average97.10% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 02-Oct-2026

Time Volume / Share Price
16:35 31 @ 3.30p
16:35 12 @ 3.30p
16:35 19 @ 3.30p
16:21 4,520 @ 3.35p
16:07 48,971 @ 3.40p

Immupharma Key Personnel

CFO Ashley Clarke

Top of Page